[ Price : $8.95]
Federal Register notice: FDA submits to OMB an information collection extension for its guidance on Formal Meetings With Sponsors ...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension-related purposes the regulatory review period for Wyeths Besponsa (in...[ Price : $8.95]
FDA warns Californias Auro Pharmacies about multiple violations in its drug compounding operations.[ Price : $8.95]
FDA commissioner Scott Gottlieb says two advisory committees will discuss ways to make naloxone more readily available to combat o...[ Price : $8.95]
FDA releases an FDA-483 with two observations from an inspection at Indias Cipla Limited.[ Price : $8.95]
FDA says a two-day meeting of the Endocrinologic and Metabolic Drugs Advisory Committee will consider changes that may be appropri...[ Price : $8.95]
Several drug companies respond to FDAs request for comments on how to proceed with Bendeka orphan drug exclusivity in light of a c...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension-related purposes the regulatory review period for Kirin-Amgens Siliq ...